Claudia Regina Lopes Cardoso

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Clínica Médica/FM

ORCID:

não disponível no Lattes


Formação:
  • Universidade Federal do Rio de Janeiro

    Medicina (Cardiologia) | Doutorado | 1996 - 2000
  • Universidade do Estado do Rio de Janeiro

    Medicina (Cardiologia) | Mestrado | 1982 - 1986
  • Universidade Federal do Rio de Janeiro

    | Especialização - Residência medica | 1980 - 1982
  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1974 - 1979
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(93.75% artigos com DOI)

Titulo DOI Ano
Impact of PNPLA3 and TM6SF2 Polymorphisms on the Prognosis of Patients with MASLD and Type 2 Diabetes Mellitus 10.1111/liv.15845 2024
Risk of Heart Failure in Ambulatory Resistant Hypertension A Meta-Analysis of Observational studies 10.1038/s41440-024-01632-8 2024
Body Weight Variability and the Risk of Liver-related outcomes in Type 2 Diabetes and Steatotic Liver Disease: a Cohort Study 10.1002/oby.24035 2024
Prognostic importance of cardiovascular autonomic neuropathy on cardiovascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort 10.1016/j.diabres.2022.110232 2023
Prognostic importance of obstructive sleep apnea and CPAP treatment for cardiovascular and mortality outcomes in patients with resistant hypertension: a prospective cohort study 10.1038/s41440-023-01193-2 2023
Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study 10.1097/hjh.0000000000003387 2023
Effects of Weight Loss and Interaction with Physical Activity on Risks of Cardiovascular Outcomes in Individuals with Type 2 Diabetes 10.3803/EnM.2023.1690. 2023
Effects of body weight variability on risks of macro- and microvascular outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort 10.1016/j.diabres.2023.110992 2023
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease 10.1007/s10620-023-08214-7 2023
Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort 10.1161/HYPERTENSIONAHA.123.21514 2023
Prognostic Value of Changes in Aortic Stiffness for Cardiovascular Outcomes and Mortality in Resistant Hypertension: a Cohort Study 10.1161/HYPERTENSIONAHA.121.18498 2022
Differential Effects of Treatment Targets on Risks of Adverse Outcomes According to Diabetes Duration, Age and Complications: Can these Characteristics be used to Individualize Diabetes Treatment? The Rio de Janeiro Type 2 Diabetes Cohort 10.1016/j.jdiacomp.2021.108124 2022
Prognostic impact of changes in aortic stiffness for cardiovascular and mortality outcomes in individuals with type 2 diabetes: the Rio de Janeiro cohort study 10.1186/s12933-022-01514-8 2022
Associations of the nocturnal blood pressure fall and morning surge with cardiovascular events and mortality in individuals with resistant hypertension 10.1097/hjh.0000000000002775 2021
Importance of Non-Invasive Liver Fibrosis Scores for Mortality and Complications Development in Individuals with Type 2 Diabetes   10.1016/j.jdiacomp.2021.107879 2021
Traditional and Non-Traditional Risk Factors for Peripheral Artery Disease Development/Progression in Patients with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1186/s12933-021-01249-y 2021
ASSOCIATIONS BETWEEN ACHIEVED AMBULATORY BLOOD PRESSURES AND ITS CHANGES WITH ADVERSE OUTCOMES IN RESISTANT HYPERTENSION: WAS THERE A J-CURVE FOR AMBULATORY BLOOD PRESSURES? 10.1161/HYPERTENSIONAHA.121.17200 2021
Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study 10.1186/s12933-021-01324-4 2021
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study 10.1186/s12933-021-01388-2 2021
Prognostic Impact of Home Blood Pressures for Adverse Cardiovascular Outcomes and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study 10.1161/HYPERTENSIONAHA.121.18064 2021
Refractory Hypertension: A Narrative Systematic Review with Emphasis on Prognosis 10.1007/s11906-022-01165-w 2021
Effects of continuous positive airway pressure treatment on aortic stiffness in patients with resistant hypertension and obstructive sleep apnea: A randomized controlled trial 10.1111/jsr.12990 2020
Prognostic Importance of Visit-to-Visit Blood Pressure Variability for Micro- and Macrovascular Outcomes in Patients with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. 10.1186/s12933-020-01030-7 2020
Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients with Resistant Hypertension: a Prospective Cohort Study 10.1161/JAHA.120.017634 2020
Prognostic Impact of Short-Term Ambulatory Blood Pressure Variability for Micro- and Macrovascular Outcomes in Patients with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1097/HJH.0000000000002710. 2020
PROGNOSTIC IMPACT OF AORTIC STIFFNESS IN PATIENTS WITH RESISTANT HYPERTENSION: A PROSPECTIVE COHORT STUDY 10.1161/HYPERTENSIONAHA.118.12367 2019
Prognostic Impact of Carotid Intima-Media Thickness and Carotid Plaques on the Development of Micro- and Macrovascular Complications in Individuals with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1186/s12933-019-0809-1 2019
Efficacy of Diacerein in Reducing Liver Steatosis and Fibrosis in Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: a Randomized, Placebo-Controlled Trial. 10.1111/dom.13643. 2019
COUNTERPOINT: Should Sleep Studies Be Performed for All Patients With Poorly Controlled Hypertension? No 10.1016/j.chest.2019.04.007 2019
Rebuttal From Drs Cardoso and Salles 10.1016/j.chest.2019.04.005 2019
PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? 10.1016/j.numecd.2019.06.002 2019
Prognostic Importance of Resistant Hypertension in Patients with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.2337/dc19-1534 2019
Importance of Aortic Stiffness and Ambulatory Blood Pressures in the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes: a Competing Risks Analysis from The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-017-4484-z 2018
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1186/s12933-018-0677-0 2018
A ATUAÇÃO DA TERAPIA OCUPACIONAL COM PACIENTES COM DIABETES TIPO 2: UMA REVISÃO DE LITERATURA 2018
Usefulness of the Vibration Perception Thresholds Measurement as a Diagnostic Method for Diabetic Peripheral Neuropathy: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1016/j.jdiacomp.2018.05.010 2018
Prognostic Impact of the Ankle-Brachial Index to Micro- and Macrovascular Complications Development in Individuals with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-018-4709-9 2018
Treatment Adherence and its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study' 10.1155/2018/8970196. 2018
Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters 10.1038/s41598-017-05159-6. 2017
Efficacy and Safety of Diacerein in Patients with Inadequately Controlled Type 2 Diabetes: a Randomized Controlled Trial 10.2337/dc17-0374. 2017
Are carotid intima media thickness and plaques related to microvascular diabetic complications development? There is still much to learn 2017
Profile of disabilities and their associated factors in patients with type 2 diabetes evaluated by the Canadian occupational performance measure: the Rio De Janeiro type 2 diabetes cohort study 10.3109/09638288.2015.1111440 2016
Prognostic Value of C-Reactive Protein in Resistant Hypertension 10.1093/ajh/hpw011 2016
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients 10.1161/HYPERTENSIONAHA.115.06981 2016
NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? 10.3390/ijms17040460 2016
Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1016/j.jdiacomp.2016.05.006 2016
Aortic stiffness: is it time to be included into clinical diabetes management? 10.1016/j.jdiacomp.2016.06.010 2016
Forearm Resistance-Vessel Dilatation Function during Reactive Hyperemia in Patients with Resistant Hypertension. 10.1093/ajh/hpw083 2016
Prognostic Importance of C¿Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1161/jaha.116.004554 2016
Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is it all that Matters? 10.1007/s11906-016-0693-y 2016
Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes 10.3390/ijms17122044 2016
Correlates of aortic stiffness progression in patients with resistant hypertension 10.1097/hjh.0000000000000491 2015
Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial 10.1161/hypertensionaha.114.04852 2015
Nitroglycerin-mediated, but not flow-mediated vasodilation, is associated with blunted nocturnal blood pressure fall in patients with resistant hypertension 10.1097/hjh.0000000000000589 2015
Correlates of Aortic Stiffness Progression in Patients With Type 2 Diabetes: Importance of Glycemic Control 10.2337/dc14-2791 2015
Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-015-3658-9 2015
Increasing Aortic Stiffness is Predictive of Advanced Liver Fibrosis in Patients with Type 2 Diabetes: the Rio-T2DM Cohort Study 10.1111/liv.12994 2015
A reduced heart rate variability is independently associated with a blunted nocturnal blood pressure fall in patients with resistant hypertension 10.1097/hjh.0000000000000068 2014
Non-Alcoholic Fatty Liver Disease and Diabetes: From Physiopathological Interplay to Diagnosis and Treatment. 10.3748/wjg.v20.i26.8377 2014
Prognostic Importance of Baseline and Serial Glycated Hemoglobin Levels in High Risk Patients with Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. 10.1007/s00592-014-0592-0 2014
Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes 10.1016/j.diabres.2014.07.005 2014
Prognostic Significance of Baseline Heart Rate and Its Interaction With Beta-Blocker Use in Resistant Hypertension: A Cohort Study 10.1093/ajh/hps004 2013
Is blood pressure response to exercise mediated by abnormal glucose and lipid metabolism in normotensive individuals? 10.1038/hr.2013.8 2013
Factors Associated with Abnormal T-wave Axis and Increased QRS-T Angle in Type 2 Diabetes. 10.1007/s00592-013-0483-9 2013
Prognostic Impact of Aortic Stiffness in High-Risk Type 2 Diabetic Patients: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.2337/dc13-0506 2013
Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis 10.1111/j.1872-034X.2012.01106.x 2013
Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients 10.1097/hjh.0b013e328364103f 2013
Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients 10.1097/hjh.0b013e328352aba6 2012
High fitness is associated with a better cardiovascular risk profile in patients with type 2 diabetes mellitus 10.1038/hr.2011.50 2011
Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension 10.1016/j.atherosclerosis.2011.01.026 2011
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors 10.1111/j.1478-3231.2011.02482.x 2011
Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension 10.1097/HJH.0b013e32834adb09 2011
Thresholds of Ambulatory Blood Pressure Associated With Chronic Complications in Type 2 Diabetes 10.1038/ajh.2011.168 2011
Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension 10.1016/j.ahj.2010.02.012 2010
Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients 10.1038/hr.2010.80 2010
Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension 10.1097/HJH.0b013e328339f9e5 2010
Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension 10.1097/HJH.0b013e32833af39a 2010
Prolonged heart rate-corrected QT interval and cardiovascular risk in Asian populations 10.1038/hr.2010.116 2010
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus 10.1111/j.1478-3231.2008.01718.x 2009
Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study 10.1097/HJH.0b013e32832720b3 2009
Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients 10.1016/j.atherosclerosis.2008.12.027 2009
Prognostic Value of Nocturnal Blood Pressure Reduction in Resistant Hypertension 10.1001/archinternmed.2009.68 2009
A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension 10.1038/hr.2009.71 2009
Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients? 10.1016/j.jdiacomp.2007.02.004 2008
Recent Ventricular Repolarization Markers in Resistant Hypertension: Are They Different from the Traditional QT Interval? 10.1038/ajh.2007.4 2008
Pattern of 24-Hour Ambulatory Blood Pressure Monitoring in Type 2 Diabetic Patients with Cardiovascular Dysautonomy 10.1291/hypres.31.865 2008
Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients 10.1007/s00296-007-0447-x 2008
Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study 10.1177/0961203308093829 2008
Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension 10.1001/archinte.168.21.2340 2008
Gross proteinuria is a strong risk predictor for cardiovascular mortality in Brazilian type 2 diabetic patients 10.1590/S0100-879X2008005000035 2008
Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients 10.1016/j.diabres.2006.04.008 2007
Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension 10.1161/HYPERTENSIONAHA.107.093120 2007
Importance of the Electrocardiographic Strain Pattern in Patients With Resistant Hypertension 10.1161/01.HYP.0000236550.90214.1c 2006
Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension 10.1038/sj.jhh.1001815 2005
Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients 10.1191/0961203305lu2124oa 2005
QT-interval parameters are increased in systemic lupus erythematosus patients 10.1191/0961203305lu2225oa 2005
T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease 10.1016/j.amjcard.2004.01.040 2004
Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients 10.2337/diacare.27.6.1299 2004
QT?interval parameters in end?stage renal disease 10.1007/s10286-004-0207-x 2004
Prognostic value of QT interval parameters in type 2 diabetes mellitus Results of a long-term follow-up prospective study 10.1016/S1056-8727(02)00206-4 2003
Electrocardiographic Ventricular Repolarization Parameters in Chronic Chagas' Disease as Predictors of Asymptomatic Left Ventricular Systolic Dysfunction 10.1046/j.1460-9592.2003.t01-1-00190.x 2003
QTc Interval Prolongation Is a Predictor of Future Strokes in Patients With Type 2 Diabetes Mellitus 10.1161/01.STR.0000085084.15144.66 2003
Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease: Results of a Long-Term Follow-Up Study 10.1161/01.CIR.0000079174.13444.9C 2003
Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients 10.1191/0961203303lu447xx 2003
Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns 10.1038/sj.jhh.1001590 2003
Ventricular repolarization in diabetes mellitus: still much to learn 10.1007/s10286-002-0053-7 2002
Clinical determinants of increased QT dispersion in patients with diabetes mellitus 10.1016/S0167-5273(01)00443-0 2001
Dispersão do intervalo QT de eletrocardiograma em diabéticos 2000
Avaliação clínica e eletromiográfica em pacientes em tratamento com talidomida 2000
Esclerose sistêmica Progressiva induzida por exposição à silica:relato de dois casos 1998
Pulsoterapia endovenosa com ciclofosfamida (CFM):avaliação preliminar de 16 pacientesem protocolode manutenção 1998
Bioprótese Mitral , avaliação clínca, radiológica, eletrocardiográfica e ecocardiográfica 1988
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Prognostic interaction between clinic and ambulatory blood pressure and glycated hemoglobin with type 2 diabetes 2014
Pognostic impact of aortic stiffness in high risk type 2 diabetic patients 2013
Associated factors with cardiac structure and function in type 2 diabetes 2013
Prognostic impact of hemoglobin A1c in high risk type 2 diabetic patients: The Rio de Janeiro Type 2 Diabetes(Rio-T2D) Cohort Study 2013
?IMPORTANCE OF CLINIC AND AMBULATORY BLOOD PRESSURES AS PREDICTORS OF ALL-CAUSE MORTALITY IN TYPE 2 DIABETES? 2012
?PROGNOSTIC IMPACT OF CLINIC AND AMBULATORY BLOOD PRESSURES FOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES? 2012
. Perfil funcional de pacientes com diabetes tipo 2 de um hospital terciário aferido pela medida Canadense de Desempenho Ocupacional e sus correlação com a qualidade de vida 2012
. Autocuidado em Diabetes Tipo 2. 2012
Prevalência de Polineuropatia distal diabética em pacientes com diabetes tipo 2 de um hospital terciário 2012
Specific damages are important predictors of mortality in Brazilian patients with Systemic Lupus Erythematosus 2011
Antiphospholipid syndrome as predictor of mortality in Brazilian patients with systemic lupus erythematosus 2011
Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients 2011
Ambulatory blood pressure monitoring parameters are better correlates of degenerative complications in type 2 diabetic patients than office blood pressures 2010
ISOLATED OFFICE HYPERTENSION IS INDEPENDENTLY ASSOCIATED WITH INCREASED CENTRAL AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES. 2009
PROGNOSTIC IMPACT OF BASELINE AND SERIAL CHANGES IN ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY IN RESISTANT HYPERTENSION. 2009
PROGNOSTIC SIGNIFICANCE OF BASELINE AND SERIAL CHANGES IN ELECTROCARDIOGRAPHIC STRAIN PATTERN IN RESISTANT HYPERTENSION. 2009
Clinical and laboratory correlates of non-alcoholic steatohepatitis and advanced fibrosis in brazilian type 2 diabetic patients 2009
High physical fitness is independently related to a better glycemic control and cardiovascular risk profile in a type 2 diabetes cohort 2009
Isolated office hypertension (white-coat effect) is indepently associated with increased central aortic stiffness in type 2 diabetes 2009
A blunted nocturnal bloood pressure reduction is associated with several unfavorable cardiovascular risk markers in type 2 diabetes 2009
Prevalence of Histopathological Diagnosis of Steatohepatitis and Fibrosis in Type 2 Diabetes and Interobserver Agreement using Kleiner Classification 2009
Factors associated with increased arterial stiffness in patients with type 2 diabetes mellitus 2008
Relationships between microalbuminuria and 24-hour ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus 2008
Prognostic value of QTc-interval duration for cardiovascular morbidity and mortality in patients with resistant hypertension 2008
Prognostic Impact of Office and Ambulatory Blood Pressures in Patients with Resistant Hypertension 2008
Clinical and laboratory correlates of moderate and severe steatosis on ultrasound (US) in Brazilian type 2 diabetic patients 2007
Long-term thalidomide use in refractory cutaneous lesions of lupus erythemathosus 2007
Relation of left ventricular hypertrophy to inflamation and endothelial dysfunction in patients with resistant hypertension 2007
Relação de hipertrofia ventricular esquerda com inflamação e disfunção endotelial em pacientes com hipertensão resistente 2007
Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with and without cardiovascular dysautonomy 2006
Factors associated with abnormal T-wave axis deviation in patients with resistant hypertension 2006
Usefulness of QT interval parameters for cardiovascular risk stratification in hypertensive 2 diabetic patients: results of a long-term follow up prospective study 2004
Prevalence of dyslipidemia and its related factors in Brazilian Systemic Lupus Erythematosus patients 2004
Ação dos antimaláricos no perfil lipídico de pacientes com lupus eritematoso sistêmico 2004
Prevalência de dislipidemia e seus fatores de risco em pacientes com lupus eritematoso 2004
Redução da Apoptose na nefrite lúpica proliferativa difusa 2004
Macrófagos induzem apoptose na glomerulonefrite lúpica 2004
Uso de talidomida nas lesões cutâneas do lúpus eritematoso 2004
Corte transversal de uma população de pacientes em pre-operatório de osteossíntes de fêmur,artroplastia de quadril e de joelho.Complicações e mortalidade intrahospitalar. 2003
Aspergilose cerebral associada a uso de corticosteroides em altas doses 2002
Parâmetros eletrocardiográficos da repolarização ventricular como preditores de disfunção sistólica ventricular esquerda assintomática em Doença de Chagas 2002
Valor prognóstico dos parâmetros eletrocardiográficos da repolarização ventricular para a estratificação de risco de mortalidade em Doença de Chagas 2002
Electrocardiographic repolarization parameters in hypertensive diabetic patients: relation to left ventricular mass and geometric patterns 2002
Anti-P ribosomal and antiphospholipid antibodies analysis in a group of patients with clinically definite multiple sclerosis 2002
Fatores relacionados ao desenvolvimento de dano grave em pacientes com lupus eritematoso sistêmico 2002
Mensuração de dano em pacientes com lupus eritematoso sistêmico. Coorte do HUCFF-UFRJ 2002
Correlação entre o índice de danos (SLICC/ACR-DI) e o tempo de corticoterapia em pacientes com lupus eritematoso sistêmico. 2001
Correlação entre o índice de danos (SLICC/ACR-DI) e o tempo de doença em pacientes com lupus eritematoso sistêmico 2001
Correlação entre o índice de danos (SLICC/ACR-DI) e o tempo de corticoterapia em pacientes com lupus eritematoso sistêmico 2001
Utilização do índice de danos (SLICC/ACR-DI) em pacientes com lupus eritematoso sistêmico 2001
Emprego do índice de danos (SLICC/ACR-DI) em pacientes com lupus eritematoso sistêmico 2001
Correlação entre o índice de danos (SLICC/ACR-DI) e o tempo de doença em pacientes com lupus eritematoso sistêmico 2001
Dispersão do intervalo QT em diabéticos com hipertensão arterial como precursor de hipertrofia ventricular esquerda. 1999
Lupus Eritematoso Profundo (Doença de Kaposi-Irgang): relato de três casos. 1999
Perfil clínico de pacientes com diabetes mellitus não insulino dependente (DMNID) em acompanhamento no Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro (HUCFF-UFRJ) 1999
Dispersão do intervalo QT do eletrocardiograma em diabéticos 1999
Avaliação das alterações eletrocardiográficas e do intervalo QT em diabéticos 1999
Talidomida nas lesões cutâneas do lupus eritematoso: experiência em 30 casos 1999
Pulsoterapia venosa com ciclofosfamida no lupus eritematoso sistêmico .Avaliação de 23 pacientes em protocolo de manutenção 1999
Publicações:
Minha Rede: